Business Strategy:

AVI adopts a practical strategy that mainly focuses on the early stage of drug discovery and development to address unmet medical needs. We are open to opportunities to co-develop or out-licensing our products worldwide with strategic partners at various development stages.

We are seeking global partnership for our inventions below,

• Preclinical candidates (further clinical development and commercialization)
    Therapeutic antibody; Vaccine
• Technology Platform (fee for service/co-development)
    SpeedyAb™
    ImmunoBuster™
    TsKill™